Analyst Ratings for Novo Nordisk (NVO)
NVO Rating Summary
NVO Price Target Summary
- Highest: $70.00 (HSBC)
- Lowest: $42.00 (TD Cowen)
- Average: $49.84
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$49.84 (+15.4%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
Avg. $ Target:
$49.84 (+15.4%)
* Over Last 12-Mos
Rating Score: 3 / 10
Percentile Rank: 26%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/10/2026 | TD Cowen » Updated 5/11/2026 |
Michael Nedelcovych | Downgrade | Hold (Buy) |
42.00 (N/A) |
38.58 (43.19) |
11.95% | Details |
| 3/2/2026 | Goldman Sachs » Updated 6/3/2026 |
James Quigley | Downgrade | Neutral (Buy) |
47.00 (41.00) |
37.62 (43.19) |
14.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
